Document Detail

Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer.
MedLine Citation:
PMID:  22267596     Owner:  NLM     Status:  Publisher    
ObjectiveMetastatic colorectal cancer (CRC) cells have a selective preference for certain target organs that cannot be explained by circulatory patterns alone. This study aimed to identify clinicopathological features and chromosomal aberrations of primary tumours associated with organ-specific CRC metastasis.DesignClinicopathological features were investigated in patients with CRC who had exclusively hepatic (n=182) versus exclusively extrahepatic (n=139) metastases. A total of 139 primary tumours of patients with hepatic (n=85) and extrahepatic metastases (n=54) were screened for chromosomal aberrations by microarray-based comparative genomic hybridisation, and the findings were validated in an independent set of 80 primary tumours. A publicly available database was used to correlate chromosomal aberrations with gene expression. Protein expression was evaluated by immunohistochemistry on tissue microarrays.ResultsPatients with hepatic metastases were significantly more often male (71% vs 53% p=0.002), more often had abnormal lactate dehydrogenase activity (37% vs 14% p<0.0001), exhibited primary tumour localisation in the colon (52% vs 40% p=0.03) and had synchronous onset of metastases (70% vs 19% p<0.0001). Primary tumours of patients with hepatic metastases were more commonly T3 tumours (79% vs 63% p=0.006) and less commonly of mucinous histology (5% vs 16% p=0.02). Gain of 20p11 was more often observed in patients with hepatic metastases (p<0.05), which was confirmed in an independent dataset (p<0.05; false discovery rate <0.05). Twelve genes mapping at 20p11 were significantly overexpressed as a consequence of 20p11 copy number gain. C20orf3 showed the strongest correlation between RNA expression and DNA copy number. This was reflected in significantly higher protein expression in patients with hepatic metastases (59%; n=325) than in those with extrahepatic metastases (41%; n=256) (p=0.01).ConclusionC20orf3 mapping at 20p11 is associated with hepatic-specific metastasis in patients with CRC. This gene is a candidate biomarker for liver metastases and may be of clinical value in early-stage CRC.
Leonie J M Mekenkamp; Josien C Haan; Miriam Koopman; M Elisa Vink-Börger; Daniëlle Israeli; Steven Teerenstra; Bauke Ylstra; Gerrit A Meijer; Cornelis J A Punt; Iris D Nagtegaal
Related Documents :
12587566 - Quranic description of gametes.
12832376 - Efficacy of the swim-up method in eliminating sperm with diminished maturity and aneupl...
16529576 - Arrest of flagellum morphogenesis with fibrous sheath immaturity of human spermatozoa.
2768106 - Long-term liquid storage of porcine spermatozoa separated using a discontinuous bovine ...
22201036 - (1)h, (13)c and (15)n resonance assignments of the kinetochore localisation domain of b...
9100576 - Y-chromosome deletions in idiopathic severe testiculopathies.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-20
Journal Detail:
Title:  Gut     Volume:  -     ISSN:  1468-3288     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985108R     Medline TA:  Gut     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hospitalisations and surgery in Crohn's disease.
Next Document:  Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.